RESEARCH IMPACT: 32 YEARS OF UNDERSTANDING, DIAGNOSING, TREATING & PREVENTING THE ONSET OF HEART DISEASE
With
Professor Jason Kovacic
CEO & Institute Director,
Victor Chang Cardiac Research Institute &
Practicing Clinical Cardiologist, St Vincent’s Hospital, Sydney Australia &
Professor of Medicine
The Icahn School of Medicine at Mount Sinai
New York, United States
RESEARCH IMPACT
Filmed in Sydney, Australia | October 2026
The Victor Chang Cardiac Research Institute is dedicated to finding cures for cardiovascular disease through world-class and cutting-edge medical research.
The Institute’s team seeks to discover better ways of understanding, diagnosing, treating, and preventing the onset of heart disease. It is committed to ensuring its research breakthroughs are rapidly translated into advances in clinical care.
The Victor Chang Cardiac Research Institute was founded in 1994 in honour of the legendary heart transplant surgeon Dr Victor Chang AC. In 1996, the late Diana, Princess of Wales, officially opened the institute in Sydney, Australia.
Beginning with just two scientists, it has more than 250 scientists, doctors, and staff working together across 26 laboratories nationwide. It is renowned for the quality of its scientific discoveries worldwide.
In 2022, the Institute expanded its national footprint by establishing a new heart disease research hub in partnership with The University of Western Australia and in 2025 announced a new collaboration with the Perth-based Harry Perkins Institute of Medical Research. It has also established hubs in South Western Sydney and Melbourne. This is allowing researchers and scientists to accelerate life-saving discoveries that benefit all Australians and deliver international impact.
The Institute is also a proud partner of the St Vincent’s Sydney Health Innovation Precinct – comprised of St Vincent’s Hospital Sydney, the Garvan Institute of Medical Research, St Vincent’s Private Hospital Sydney and St Vincent’s Clinic.
In this interview on the impact of research undertaken by the Victor Chang Cardiac Research Institute, Professor Jason Kovacic talks about the following studies:
- Funnel web spider venom to develop world’s first cardiac protective drug for heart transplants and heart attacks https://doi.org/10.1161/CIRCULATIONAHA.121.054360
- Discovery and role of PHACTR1 gene in vascular diseases including spontaneous coronary artery dissection (SCAD) https://doi.org/10.1016/j.jacc.2018.09.085
- Artificial intelligence and machine learning to predict disease progression & better outcomes of aortic stenosis https://doi.org/10.3389/fcvm.2023.1153814
Source: Victor Chang Cardiac Research Institute website
-
Dr Nischal Sahai
RESEARCH IN DEVICE TRIALS, VACCINE STUDIES, ORAL MEDICATIONS, INJECTABLES & INFUSIONS.
@ CLINICAL TRIAL CENTRE, UNIVERSITY OF THE SUNSHINE COAST
QUEENSLAND, AUSTRALIA -
RESEARCH IMPACT: 35 years of kids’ health research
The Kids Research Institute Australia is one of the largest and most successful medical research institutes in Australia. The Institute has created a blueprint that brings together community, researchers, practitioners, policy makers and funders, who share our vision to improve the health and wellbeing of children through excellence in research. In November 2025, The Kids Research Institute Australia celebrated 35 years of bold ideas, groundbreaking research, and the people who find answers to the big questions about better health outcomes for children and families.
-
Prescribing exercise to regional population with cardiovascular disease & diabetes
Associate Professor Gordon’s research is aimed at determining the optimal methods of prescribing and implementing exercise as part of the health care plan for people with cardiovascular disease and diabetes. Specifically, he is leading work to determine if and how the components of exercise can be considered as a whole for prescribing exercise to generate health benefits. This is important to overcome the series of barriers that people living in rural and regional areas experience when trying to become active.
